Scholarly Index
Peter J. O’Dwyer
University of Pennsylvania; 41,892 total citations; 527 total publications; best world rank #138
University of Pennsylvania
41,892Total citations
527Total publications
86H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Colorectal Cancer Treatments and Studies | Lifetime | 138 | US 71 | 99.51 |
| Cancer Treatment and Pharmacology | Lifetime | 262 | US 145 | 99.19 |
| Cancer therapeutics and mechanisms | Lifetime | 229 | US 137 | 98.68 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 550 | US 263 | 98.53 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 870 | US 369 | 98.17 |
| Bioactive Compounds and Antitumor Agents | Lifetime | 304 | US 114 | 96.57 |
| Advanced Breast Cancer Therapies | Lifetime | 312 | US 145 | 97.48 |
| Genomics, phytochemicals, and oxidative stress | Lifetime | 477 | US 168 | 96.00 |
| Melanoma and MAPK Pathways | Lifetime | 386 | US 207 | 96.14 |
| Neutropenia and Cancer Infections | Lifetime | 570 | US 257 | 95.40 |
| Glutathione Transferases and Polymorphisms | Lifetime | 826 | US 327 | 90.09 |
| Chemotherapy-induced organ toxicity mitigation | Lifetime | 424 | US 109 | 87.54 |
| Gestational Trophoblastic Disease Studies | Lifetime | 940 | US 327 | 78.87 |
| Colorectal Cancer Treatments and Studies | 2021-2025 | 973 | US 260 | 89.00 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 933 | US 314 | 60.14 |